Relaxium Sleep for Occasional Insomnia
The American Academy of Sleep Medicine (AASM) explicitly recommends against using melatonin for the treatment of sleep onset or sleep maintenance insomnia in adults, and Relaxium Sleep—a melatonin-based supplement—falls under this negative recommendation. 1
Evidence Against Melatonin-Based Products
The AASM 2017 clinical practice guideline states that clinicians should NOT use melatonin as a treatment for sleep onset or sleep maintenance insomnia versus no treatment in adults, based on trials of 2 mg doses showing insufficient efficacy. 1
The quality of evidence for melatonin was rated as "very low" with benefits approximately equal to harms, and the majority of patients would not choose this treatment over no treatment. 1
The American College of Physicians (2016) similarly found insufficient evidence for melatonin efficacy, with small effect sizes that did not meaningfully improve global or sleep outcomes. 2
What Relaxium Sleep Actually Contains
According to FDA labeling, Relaxium Sleep is marketed for "occasional sleeplessness" and "restless sleep," but these claims are based on traditional homeopathic practice, not accepted medical evidence and not FDA evaluated. 3
The product is melatonin-free according to its own labeling, instead containing homeopathic dilutions (C, K, CK, and X dilutions) of unspecified ingredients. 3
The FDA label warns to stop use and consult a physician if sleeplessness persists continuously for more than 2 weeks or worsens, as insomnia may indicate a serious underlying illness. 3
Recommended Evidence-Based Alternatives
If pharmacologic treatment is needed for occasional insomnia, the AASM recommends the following agents instead:
For Sleep Onset Insomnia:
- Zaleplon 10 mg is the preferred first-line option due to its rapid onset, shortest half-life, and lowest risk of next-day somnolence. 4
- Zolpidem 10 mg can be used for both sleep onset and maintenance difficulties. 1, 4
- Ramelteon 8 mg (a melatonin receptor agonist, distinct from melatonin itself) is recommended for sleep onset insomnia. 1
Agents to Avoid:
- Diphenhydramine (over-the-counter antihistamine) is NOT recommended due to anticholinergic effects and limited efficacy evidence. 1, 4
- Trazodone 50 mg is NOT recommended due to lack of efficacy data and significant adverse effects. 1, 4
Important Caveats About Melatonin Research
Recent meta-analyses (2024) suggest that higher doses (4 mg) taken 3 hours before bedtime may be more effective than the commonly used 2 mg dose taken 30 minutes before sleep, but this contradicts guideline recommendations. 5
Safety data for melatonin doses ≥10 mg show a good overall safety profile with increased minor adverse events (drowsiness, headache, dizziness) but no increase in serious adverse events, though long-term safety data remain limited. 6
Melatonin's sleep-promoting effect is modest and variable, primarily advancing sleep onset time by small amounts (typically <20 minutes) with minimal impact on total sleep time or sleep efficiency. 7
Clinical Algorithm
Assess insomnia duration: If symptoms persist >2 weeks, evaluate for underlying medical or psychiatric conditions rather than using over-the-counter supplements. 3
Consider non-pharmacologic approaches first: Cognitive-behavioral therapy for insomnia (CBT-I) is the gold standard first-line treatment. 4
If pharmacotherapy is warranted: Use AASM-recommended agents (zaleplon, zolpidem, or ramelteon) rather than melatonin-based or homeopathic products. 1, 4
Avoid Relaxium Sleep: It lacks evidence-based support, contains homeopathic dilutions of uncertain clinical value, and falls under the category of products not recommended by major sleep medicine guidelines. 1, 3